Studentshare
Subjects
Finance & Accounting
Accounting Issues and Solutions in Pharmaceuticals

Accounting Issues and Solutions in Pharmaceuticals - Dissertation Example

Add to wishlist

Summary

The paper "Accounting Issues and Solutions in Pharmaceuticals" debates financial managers and economists regarding the fact pertaining to the accounting treatment of research and development expenditure in the financial statements of pharmaceutical companies…

Download full paper File format: .doc, available for editing

GRAB THE BEST PAPER96% of users find it useful

Accounting Issues and Solutions in Pharmaceuticals

Read Text Preview

Subject: Finance & Accounting
Type: Dissertation
Level: Masters
Pages: 60 (15000 words)
Downloads: 2
Author: sabinakoch

Extract of sample "Accounting Issues and Solutions in Pharmaceuticals"

Download file to see previous pages

This particular, in addition to providing a brief historical background of the R&D accounting treatments, highlights the following main R&D accounting issues and their most prudent accounting treatment in the financial statements of a pharmaceutical company:

Goodwill accounting during merger and acquisition transactions between multinational
Exchange of intangible assets with continuing involvement
Upfront payments to conduct research with access to the research
Payments made to conduct research
Upfront payments received to conduct development: Interim recognition
Upfront payments received to conduct development: Completion
Donation payment for research
Loans received to fund research and development purposes
Segmental reporting of internal research and development
Treatment of development supplies
Advertising and promotional expenditure
Accounting for the cost of free samples
Line extension development costs

The paper also presents the linkage between research and development expenditure and financial viability. For this purpose, the last three financial years of AstraZeneca are used.

Introduction

The top of the worldwide pharmaceutical market is the US and it is expected to hit almost $345 billion in 2014. The second largest market is the Japanese market and then the European market including Germany France, and the Chinese market (Market line industry guide, 2012). However, the International Federation of Pharmaceutical Wholesalers (IFPW) shows that growth rates in developed and developing markets based on their capability to recover from the economic crisis are significantly inconsistent. According to the research of Urch Publishing (2012), the global pharmaceutical industry in 2014 is expected to be worth over $1 trillion with a 5% compound annual growth rate. The pharmaceutical industry becomes more competitive.

Table5 displays major competitors in the pharmaceutical industry. Moreover, major important competitors of AstraZeneca include Actelion Ltd, Ashton Corporation, Aeolus Pharmaceuticals, Inc., and Indevus Pharmaceuticals, Inc as well (MarketLine 2012, p27).

Table5 Major competitor companies

Company

HQ location

Pharmaceutical Segment Sales

Total revenue

Share of pharmaceutical segment

$Million

Johnson & Johnson

25,400

67,224

38%

Pfizer

51,214

58,986

87%

Novartis

Switzerland

32,153

56,673

57%

Merck

40,601

47,267

86%

Roche

Switzerland

35,200

45,500

77%

Sanofi-Aventis

France

39,940

42435

94%

AstraZeneca

43,143

100%

GlaxoSmithKline

27,758

40,722

68%

Eli Lily

19,934

22,603

88%

Source: 2012 Annual Report of the companies

...Download file to see next pages Read More

Cite this document

APA
MLA
CHICAGO

(“Issues in accounting for R&D investment - a perspective from the Dissertation”, n.d.)
Issues in accounting for R&D investment - a perspective from the Dissertation. Retrieved from https://studentshare.org/finance-accounting/1483141-issues-in-accounting-for-rd-investment-a

(Issues in Accounting for R&D Investment - a Perspective from the Dissertation)
Issues in Accounting for R&D Investment - a Perspective from the Dissertation. https://studentshare.org/finance-accounting/1483141-issues-in-accounting-for-rd-investment-a.

“Issues in Accounting for R&D Investment - a Perspective from the Dissertation”, n.d. https://studentshare.org/finance-accounting/1483141-issues-in-accounting-for-rd-investment-a.

Cited: 0 times

CHECK THESE SAMPLES OF Accounting Issues and Solutions in Pharmaceuticals

Change Reseach Project part 2

The Management of Change in the Pharmaceutical Industry – Janssen Pharmaceutical Inc....

12 Pages (3000 words) Research Paper

The Agreement on Trade-Related Aspects of Intellectual Property Rights

The paper "The Agreement on Trade-Related Aspects of Intellectual Property Rights" states that the TRIPS Agreement, despite the controversies surrounding it and the disagreements of Members to date, has produced favourable results for developing countries.... ... ... ... The imperative to provide special concessions to help developing countries cope and progress may be viewed from two perspectives: one is from the point of view of economics, because developed countries need the markets in developing economies to propel their further growth, and unhealthy markets will work to the detriment of this growth prospect....

62 Pages (15500 words) Dissertation

Fluorescence Impacting Pharmaceuticals

This essay "Fluorescence Impacting pharmaceuticals" discusses how fluorescence illumination and observation is one of the most rapidly expanding technologies of our time when it is concerned with the staggering achievements of science and technology in the fields of Medicine, Biochemistry, Biotechnology, and pharmaceuticals.... When applied to the field of study of pharmaceuticals and their effect on cell systems, this can allow one to study the phenomenal response in fluorescence to localized cellular environmental variables, such as variation in pH, viscosity, refractive index, ionic concentrations, membrane potentials, and solvent polarity in living cell systems and tissue preparations with extraordinary sensitivity....

7 Pages (1750 words) Essay

Professional Development Article

The Pharma Industry audit is much more unique than other well-known, independent auditing firms as it deals with much more than simple accounting issues and financial numbers.... ontained in the article are many pharmaceutical companies and their profitability achieved for 2007-2008, their innovation focus, accounting, and how each firm has positioned itself for growth or loss in the face of how each firm chooses to market its products or its research and development efforts....

5 Pages (1250 words) Essay

Challenges to the Pharmaceutical Industrys Blockbuster-Driven Business Model

Many pharmaceuticals that launched blockbuster models between 1995 and 2000 were the outcome of discovery events began between the 1970s and 1980s (Ding et al.... pharmaceuticals made these efforts to commercialize the upsurge of scientific understanding that had been growing for two decades.... Increases in development costs pose another challenge for pharmaceuticals' blockbuster strategies (Shore, 2012, p.... The deterioration of patent protection contributed significantly to the collapse of blockbuster-driven business models among pharmaceuticals (Rickwood, 2012)....

7 Pages (1750 words) Assignment

Corporate Social Responsibility and Financial Performance of the Company

This assignment "Corporate Social Responsibility and Financial Performance of the Company" develops in-depth knowledge pertaining to the topic of corporate social responsibility (CSR).... It covers all the topics that are related to CSR and its application in the real world.... .... ... ... The literature highlights the opinion of different authors, who have written several articles related to the topic....

28 Pages (7000 words) Assignment

Corporate Governance Reform - Guangzhou Pharmaceutical Holdings Limited

The paper 'Corporate Governance Reform - Guangzhou Pharmaceutical Holdings Limited" is a great example of a management report.... Corporate governance is often described as the system through which a company is controlled and administered.... ... ... ... The paper 'Corporate Governance Reform - Guangzhou Pharmaceutical Holdings Limited" is a great example of a management report....

19 Pages (4750 words) Report

Novo Nordisk as a Leader in Producing New Drugs

Novo Nordisk, therefore, belongs to the pharmaceuticals and Health Care industry.... For nearly 90 years of existence, the firm has integrated the discovery of drugs and technology, thus using science to provide solutions for patients with a diabetic condition.... It is with pleasure that I bring to you, the reader, Novo Nordisk's most significant dimensions of organizational strategy and discuss the most appropriate management accounting system for the company....

10 Pages (2500 words) Term Paper